This report contains market size and forecasts of Nausea And Vomiting Treatment in Global, including the following market information:
Global Nausea And Vomiting Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Nausea And Vomiting Treatment market was valued at 5086.7 million in 2020 and is projected to reach US$ 6475.5 million by 2027, at a CAGR of 6.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nausea And Vomiting Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nausea And Vomiting Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Nausea And Vomiting Treatment Market Segment Percentages, By Type, 2020 (%)
Serotonin Receptor Antagonist
Neurokinin NK1 Receptor Antagonist
Other
China Nausea And Vomiting Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Nausea And Vomiting Treatment Market Segment Percentages, By Application, 2020 (%)
CINV
PONV
Motion Sickness
Pregnancy
Others
Global Nausea And Vomiting Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Nausea And Vomiting Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Nausea And Vomiting Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Nausea And Vomiting Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Merck & Co. Inc.
Helsinn Group
Unimed Pharmaceuticals (AbbVie Inc.)
Kyowa Kirin
Sanofi
Qilu Pharma
Teva Pharmaceutical Industries Ltd.
Taiji group
Novartis
Heron Therapeutics
Atnahs Pharma UK Limited
Mylan
Duchesnay
Tesaro
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Nausea And Vomiting Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nausea And Vomiting Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nausea And Vomiting Treatment Overall Market Size
2.1 Global Nausea And Vomiting Treatment Market Size: 2021 VS 2027
2.2 Global Nausea And Vomiting Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nausea And Vomiting Treatment Players in Global Market
3.2 Top Global Nausea And Vomiting Treatment Companies Ranked by Revenue
3.3 Global Nausea And Vomiting Treatment Revenue by Companies
3.4 Top 3 and Top 5 Nausea And Vomiting Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Nausea And Vomiting Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nausea And Vomiting Treatment Players in Global Market
3.6.1 List of Global Tier 1 Nausea And Vomiting Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Nausea And Vomiting Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nausea And Vomiting Treatment Market Size Markets, 2021 & 2027
4.1.2 Serotonin Receptor Antagonist
4.1.3 Neurokinin NK1 Receptor Antagonist
4.1.4 Other
4.2 By Type - Global Nausea And Vomiting Treatment Revenue & Forecasts
4.2.1 By Type - Global Nausea And Vomiting Treatment Revenue, 2016-2021
4.2.2 By Type - Global Nausea And Vomiting Treatment Revenue, 2022-2027
4.2.3 By Type - Global Nausea And Vomiting Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nausea And Vomiting Treatment Market Size, 2021 & 2027
5.1.2 CINV
5.1.3 PONV
5.1.4 Motion Sickness
5.1.5 Pregnancy
5.1.6 Others
5.2 By Application - Global Nausea And Vomiting Treatment Revenue & Forecasts
5.2.1 By Application - Global Nausea And Vomiting Treatment Revenue, 2016-2021
5.2.2 By Application - Global Nausea And Vomiting Treatment Revenue, 2022-2027
5.2.3 By Application - Global Nausea And Vomiting Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Nausea And Vomiting Treatment Market Size, 2021 & 2027
6.2 By Region - Global Nausea And Vomiting Treatment Revenue & Forecasts
6.2.1 By Region - Global Nausea And Vomiting Treatment Revenue, 2016-2021
6.2.2 By Region - Global Nausea And Vomiting Treatment Revenue, 2022-2027
6.2.3 By Region - Global Nausea And Vomiting Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Nausea And Vomiting Treatment Revenue, 2016-2027
6.3.2 US Nausea And Vomiting Treatment Market Size, 2016-2027
6.3.3 Canada Nausea And Vomiting Treatment Market Size, 2016-2027
6.3.4 Mexico Nausea And Vomiting Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Nausea And Vomiting Treatment Revenue, 2016-2027
6.4.2 Germany Nausea And Vomiting Treatment Market Size, 2016-2027
6.4.3 France Nausea And Vomiting Treatment Market Size, 2016-2027
6.4.4 U.K. Nausea And Vomiting Treatment Market Size, 2016-2027
6.4.5 Italy Nausea And Vomiting Treatment Market Size, 2016-2027
6.4.6 Russia Nausea And Vomiting Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Nausea And Vomiting Treatment Market Size, 2016-2027
6.4.8 Benelux Nausea And Vomiting Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Nausea And Vomiting Treatment Revenue, 2016-2027
6.5.2 China Nausea And Vomiting Treatment Market Size, 2016-2027
6.5.3 Japan Nausea And Vomiting Treatment Market Size, 2016-2027
6.5.4 South Korea Nausea And Vomiting Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Nausea And Vomiting Treatment Market Size, 2016-2027
6.5.6 India Nausea And Vomiting Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Nausea And Vomiting Treatment Revenue, 2016-2027
6.6.2 Brazil Nausea And Vomiting Treatment Market Size, 2016-2027
6.6.3 Argentina Nausea And Vomiting Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nausea And Vomiting Treatment Revenue, 2016-2027
6.7.2 Turkey Nausea And Vomiting Treatment Market Size, 2016-2027
6.7.3 Israel Nausea And Vomiting Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Nausea And Vomiting Treatment Market Size, 2016-2027
6.7.5 UAE Nausea And Vomiting Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Merck & Co. Inc.
7.1.1 Merck & Co. Inc. Corporate Summary
7.1.2 Merck & Co. Inc. Business Overview
7.1.3 Merck & Co. Inc. Nausea And Vomiting Treatment Major Product Offerings
7.1.4 Merck & Co. Inc. Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.1.5 Merck & Co. Inc. Key News
7.2 Helsinn Group
7.2.1 Helsinn Group Corporate Summary
7.2.2 Helsinn Group Business Overview
7.2.3 Helsinn Group Nausea And Vomiting Treatment Major Product Offerings
7.2.4 Helsinn Group Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.2.5 Helsinn Group Key News
7.3 Unimed Pharmaceuticals (AbbVie Inc.)
7.3.1 Unimed Pharmaceuticals (AbbVie Inc.) Corporate Summary
7.3.2 Unimed Pharmaceuticals (AbbVie Inc.) Business Overview
7.3.3 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Major Product Offerings
7.3.4 Unimed Pharmaceuticals (AbbVie Inc.) Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.3.5 Unimed Pharmaceuticals (AbbVie Inc.) Key News
7.4 Kyowa Kirin
7.4.1 Kyowa Kirin Corporate Summary
7.4.2 Kyowa Kirin Business Overview
7.4.3 Kyowa Kirin Nausea And Vomiting Treatment Major Product Offerings
7.4.4 Kyowa Kirin Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.4.5 Kyowa Kirin Key News
7.5 Sanofi
7.5.1 Sanofi Corporate Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Nausea And Vomiting Treatment Major Product Offerings
7.5.4 Sanofi Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.5.5 Sanofi Key News
7.6 Qilu Pharma
7.6.1 Qilu Pharma Corporate Summary
7.6.2 Qilu Pharma Business Overview
7.6.3 Qilu Pharma Nausea And Vomiting Treatment Major Product Offerings
7.6.4 Qilu Pharma Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.6.5 Qilu Pharma Key News
7.7 Teva Pharmaceutical Industries Ltd.
7.7.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.7.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.7.3 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Major Product Offerings
7.4.4 Teva Pharmaceutical Industries Ltd. Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.7.5 Teva Pharmaceutical Industries Ltd. Key News
7.8 Taiji group
7.8.1 Taiji group Corporate Summary
7.8.2 Taiji group Business Overview
7.8.3 Taiji group Nausea And Vomiting Treatment Major Product Offerings
7.8.4 Taiji group Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.8.5 Taiji group Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Nausea And Vomiting Treatment Major Product Offerings
7.9.4 Novartis Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.9.5 Novartis Key News
7.10 Heron Therapeutics
7.10.1 Heron Therapeutics Corporate Summary
7.10.2 Heron Therapeutics Business Overview
7.10.3 Heron Therapeutics Nausea And Vomiting Treatment Major Product Offerings
7.10.4 Heron Therapeutics Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.10.5 Heron Therapeutics Key News
7.11 Atnahs Pharma UK Limited
7.11.1 Atnahs Pharma UK Limited Corporate Summary
7.11.2 Atnahs Pharma UK Limited Business Overview
7.11.3 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Major Product Offerings
7.11.4 Atnahs Pharma UK Limited Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.11.5 Atnahs Pharma UK Limited Key News
7.12 Mylan
7.12.1 Mylan Corporate Summary
7.12.2 Mylan Business Overview
7.12.3 Mylan Nausea And Vomiting Treatment Major Product Offerings
7.12.4 Mylan Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.12.5 Mylan Key News
7.13 Duchesnay
7.13.1 Duchesnay Corporate Summary
7.13.2 Duchesnay Business Overview
7.13.3 Duchesnay Nausea And Vomiting Treatment Major Product Offerings
7.13.4 Duchesnay Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.13.5 Duchesnay Key News
7.14 Tesaro
7.14.1 Tesaro Corporate Summary
7.14.2 Tesaro Business Overview
7.14.3 Tesaro Nausea And Vomiting Treatment Major Product Offerings
7.14.4 Tesaro Nausea And Vomiting Treatment Revenue in Global (2016-2021)
7.14.5 Tesaro Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Nausea And Vomiting Treatment Market Opportunities & Trends in Global Market
Table 2. Nausea And Vomiting Treatment Market Drivers in Global Market
Table 3. Nausea And Vomiting Treatment Market Restraints in Global Market
Table 4. Key Players of Nausea And Vomiting Treatment in Global Market
Table 5. Top Nausea And Vomiting Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Nausea And Vomiting Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Nausea And Vomiting Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Nausea And Vomiting Treatment Product Type
Table 9. List of Global Tier 1 Nausea And Vomiting Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nausea And Vomiting Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type